Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Group Shantou Jinshi Pharmaceutical is a major pharmaceutical manufacturing subsidiary of the state-owned Sinopharm Group, located in Shantou, China. The company is a key production base for antibiotics, including penicillins and cephalosporins, and produces a variety of other therapeutic agents for cardiovascular and respiratory health. It operates multiple GMP-certified production lines for both active pharmaceutical ingredients (APIs) and finished dosage forms like tablets, capsules, and injections. With a history dating back to 1970, the company has evolved from a local factory into a significant player within the national pharmaceutical supply chain. Its products are distributed widely across China and exported to numerous international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Group Shantou Jinshi Pharmaceutical.